How ATP and dATP reposition class III ribonucleotide reductase cone domains to regulate enzyme activity
Science Advances · 2025
DOI: 10.1126/sciadv.ady9156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Gisele A Andree und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Ribonucleotide Reductases, Deoxyadenine Nucleotides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIEHS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Ribonucleotide reductases (RNRs) catalyze the conversion of ribonucleotides to deoxyribonucleotides. In the majority of cases, RNR activity is allosterically regulated by the cellular 2′-deoxyadenosine 5′-triphosphate (dATP)/adenosine 5′-triphosphate (ATP) ratio. To investigate allosteric activity regulation in anaerobic or class III (glycyl radical containing) RNRs, we determine cryo–electron microscopy structures of the class III RNR from Streptococcus thermophilus (StNrdD). We find that StNrdD’s regulatory “cone” domains adopt markedly different conformations depending on whether the activator ATP or the inhibitor dATP is bound and that these different conformations alternatively position an “active site flap” toward the active site (ATP-bound) or away (dATP-bound). In contrast, the position of the glycyl radical domain is unaffected by the cone domain conformations, suggesting that StNrdD activity is regulated through control of substrate binding rather than control of radical transfer. Hydrogen-deuterium exchange mass spectrometry and mutagenesis support the structural findings. In addition, our structural data provide insight into the molecular basis by which ATP and dATP binding lead to the observed differential cone domain conformations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.
ORCID-Profile: Gisele A Andree, Kelsey R Miller-Brown, Zhuangyu Zhao, Ally K Smith, Daniel J Deredge, Catherine L Drennan
Förderung
- NIGMS NIH HHS
- NIEHS NIH HHS
- National Institutes of Health
- Howard Hughes Medical Institute
- University of Maryland Baltimore
Zitieren
APA
Andree, G. A., Miller-Brown, K. R., Zhao, Z., Smith, A. K., Dawson, C. D., Deredge, D. J., & Drennan, C. L. (2025). How ATP and dATP reposition class III ribonucleotide reductase cone domains to regulate enzyme activity. Science Advances. https://doi.org/10.1126/sciadv.ady9156
Vancouver
Andree GA, Miller-Brown KR, Zhao Z, Smith AK, Dawson CD, Deredge DJ, et al. How ATP and dATP reposition class III ribonucleotide reductase cone domains to regulate enzyme activity. Science Advances. 2025. doi:10.1126/sciadv.ady9156
BibTeX
@article{Andree2025,
author = {Andree, Gisele A and Miller-Brown, Kelsey R and Zhao, Zhuangyu and Smith, Ally K and Dawson, Christopher D and Deredge, Daniel J and Drennan, Catherine L},
title = {How ATP and dATP reposition class III ribonucleotide reductase cone domains to regulate enzyme activity},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.ady9156}
}
EUVIMED